1. Home
  2. PRZO vs RGNT Comparison

PRZO vs RGNT Comparison

Compare PRZO & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ParaZero Technologies Ltd.

PRZO

ParaZero Technologies Ltd.

N/A

Current Price

$0.49

Market Cap

16.9M

Sector

N/A

ML Signal

N/A

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.28

Market Cap

14.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRZO
RGNT
Founded
2014
2004
Country
Israel
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.9M
14.3M
IPO Year
2022
2022

Fundamental Metrics

Financial Performance
Metric
PRZO
RGNT
Price
$0.49
$1.28
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 246.9K
39.4K
Earning Date
08-26-2026
09-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$1.16
52 Week High
$1.52
$15.50

Technical Indicators

Market Signals
Indicator
PRZO
RGNT
Relative Strength Index (RSI) 37.29 38.19
Support Level $0.46 $1.23
Resistance Level $0.56 $2.52
Average True Range (ATR) 0.04 0.15
MACD 0.00 0.01
Stochastic Oscillator 39.70 20.97

Price Performance

Historical Comparison
PRZO
RGNT

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd operates as an aerospace defense company focused on the development of smart, autonomous solutions for the manned and unmanned aerial systems (UAS) industry. The Company develops, manufactures, markets, and sells counter-UAS net-launching platforms designed to protect against hostile drones in both battlefield and urban environments, precision aerial delivery systems for military applications, and smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond visual line-of-sight. The Company sells its products internationally.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: